The Artificial Cornea and Corneal Implant Market have experienced significant growth, with a valuation of USD 459.7 million in 2023. Projections indicate further expansion, with expectations reaching USD 813.7 million by 2031. This growth is propelled by the increasing prevalence of corneal disorders and the growing demand for innovative solutions to address corneal transplantation challenges. With an anticipated compound annual growth rate (CAGR) of 7.4% over the forecast period from 2024 to 2031, the market is poised for steady development, driven by advancements in biomaterials, surgical techniques, and regenerative medicine approaches aimed at improving visual outcomes and enhancing the quality of life for patients with corneal diseases.